Dean Wang1, Hongbo Tan2, Amir H Lebaschi2, Yusuke Nakagawa2, Susumu Wada2, Patrick E Donnelly2, Liang Ying2, Xiang-Hua Deng2, Scott A Rodeo3. 1. Sports Medicine and Shoulder Service, New York, New York, U.S.A.; Laboratory for Joint Tissue Repair and Regeneration, Hospital for Special Surgery, New York, New York, U.S.A.. Electronic address: deanwangmd@gmail.com. 2. Laboratory for Joint Tissue Repair and Regeneration, Hospital for Special Surgery, New York, New York, U.S.A. 3. Sports Medicine and Shoulder Service, New York, New York, U.S.A.; Laboratory for Joint Tissue Repair and Regeneration, Hospital for Special Surgery, New York, New York, U.S.A.
Abstract
PURPOSE: To investigate the use of kartogenin (KGN) in augmenting healing of the repaired enthesis after rotator cuff repair in a murine model. METHODS: Seventy-two C57BL/6 wild-type mice underwent unilateral detachment and transosseous repair of the supraspinatus tendon augmented with either fibrin sealant (control group; n = 36) or fibrin sealant containing 100 μmol/L of KGN (experimental group; n = 36) applied at the repair site. Postoperatively, mice were allowed free cage activity without immobilization. Mice were humanely killed at 2 and 4 weeks postoperatively. Repair site integrity was evaluated histologically through fibrocartilage formation and collagen fiber organization and biomechanically through load-to-failure testing of the supraspinatus tendon-bone construct. RESULTS: At 2 weeks, no differences were noted in percent area of fibrocartilage, collagen organization, or ultimate strength between groups. At 4 weeks, superior collagen fiber organization (based on collagen birefringence [17.3 ± 2.0 vs 7.0 ± 6.5 integrated density/μm2; P < .01]) and higher ultimate failure loads (3.5 ± 0.6 N vs 2.3 ± 1.1 N; P = .04) were seen in the KGN group. The percent area of fibrocartilage (13.2 ± 8.4% vs 4.4 ± 5.4%; P = .04) was higher in the control group compared with the KGN group. CONCLUSIONS: Rotator cuff repair augmentation with KGN improved the collagen fiber organization and biomechanical strength of the tendon-bone interface at 4 weeks in a murine model. CLINICAL RELEVANCE: These findings have implications for improving the structural integrity of the repaired enthesis and potentially reducing the retear rate after rotator cuff repair, which can ultimately lead to improvements in clinical outcomes.
PURPOSE: To investigate the use of kartogenin (KGN) in augmenting healing of the repaired enthesis after rotator cuff repair in a murine model. METHODS: Seventy-two C57BL/6 wild-type mice underwent unilateral detachment and transosseous repair of the supraspinatus tendon augmented with either fibrin sealant (control group; n = 36) or fibrin sealant containing 100 μmol/L of KGN (experimental group; n = 36) applied at the repair site. Postoperatively, mice were allowed free cage activity without immobilization. Mice were humanely killed at 2 and 4 weeks postoperatively. Repair site integrity was evaluated histologically through fibrocartilage formation and collagen fiber organization and biomechanically through load-to-failure testing of the supraspinatus tendon-bone construct. RESULTS: At 2 weeks, no differences were noted in percent area of fibrocartilage, collagen organization, or ultimate strength between groups. At 4 weeks, superior collagen fiber organization (based on collagen birefringence [17.3 ± 2.0 vs 7.0 ± 6.5 integrated density/μm2; P < .01]) and higher ultimate failure loads (3.5 ± 0.6 N vs 2.3 ± 1.1 N; P = .04) were seen in the KGN group. The percent area of fibrocartilage (13.2 ± 8.4% vs 4.4 ± 5.4%; P = .04) was higher in the control group compared with the KGN group. CONCLUSIONS: Rotator cuff repair augmentation with KGN improved the collagen fiber organization and biomechanical strength of the tendon-bone interface at 4 weeks in a murine model. CLINICAL RELEVANCE: These findings have implications for improving the structural integrity of the repaired enthesis and potentially reducing the retear rate after rotator cuff repair, which can ultimately lead to improvements in clinical outcomes.
Authors: John Apostolakos; Thomas Js Durant; Corey R Dwyer; Ryan P Russell; Jeffrey H Weinreb; Farhang Alaee; Knut Beitzel; Mary Beth McCarthy; Mark P Cote; Augustus D Mazzocca Journal: Muscles Ligaments Tendons J Date: 2014-11-17
Authors: Mark A Slabaugh; Shane J Nho; Robert C Grumet; Joseph B Wilson; Shane T Seroyer; Rachel M Frank; Anthony A Romeo; Matthew T Provencher; Nikhil N Verma Journal: Arthroscopy Date: 2010-01-15 Impact factor: 4.772
Authors: Kristen Johnson; Shoutian Zhu; Matthew S Tremblay; Joshua N Payette; Jianing Wang; Laure C Bouchez; Shelly Meeusen; Alana Althage; Charles Y Cho; Xu Wu; Peter G Schultz Journal: Science Date: 2012-04-05 Impact factor: 47.728
Authors: Amir Lebaschi; Xiang-Hua Deng; Jianchun Zong; Guang-Ting Cong; Camila B Carballo; Zoe M Album; Christopher Camp; Scott A Rodeo Journal: Ann N Y Acad Sci Date: 2016-10-10 Impact factor: 5.691
Authors: Helen L Moser; Adam C Abraham; Kristen Howell; Damien Laudier; Matthias A Zumstein; Leesa M Galatz; Alice H Huang Journal: J Orthop Res Date: 2020-06-15 Impact factor: 3.102